Vectura

Inhalation is our focus. With more than 20 years’ experience, we help customers and partners succeed in bringing inhaled medicines to market. Customers choose us for our unique combination of inhalation development expertise, formulation science and device technology.

As an international community of scientists, engineers, regulatory specialists, quality managers and more, we working closely together to develop innovative, inhaled product development solutions that meet our customers’ needs and, ultimately, improve patients’ lives.

Our partners have succeeded in bringing DPI, pMDI and nebuliser medicines to market with the help of our specialist capabilities.

Our combination of formulation science, device technology and inhaled development expertise has contributed to the success of 11 inhaled medicines, launched by our partners and licensees.

Since launch, they have generated $10 billion in sales and in 2018 these products were used by 9 million patients worldwide.